Related references
Note: Only part of the references are listed.Human and Rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H Demonstrate a Conserved Capacity To Restrict Vif-Deficient HIV-1
Judd F. Hultquist et al.
JOURNAL OF VIROLOGY (2011)
Genetic Editing of Herpes Simplex Virus 1 and Epstein-Barr Herpesvirus Genomes by Human APOBEC3 Cytidine Deaminases in Culture and In Vivo
Rodolphe Suspene et al.
JOURNAL OF VIROLOGY (2011)
Analysis of Human APOBEC3H Haplotypes and Anti-Human Immunodeficiency Virus Type 1 Activity
Xiaojun Wang et al.
JOURNAL OF VIROLOGY (2011)
Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism
Rodolphe Suspene et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Differential virus restriction patterns of rhesus macaque and human APOBEC3A: Implications for lentivirus evolution
Kimberly Schmitt et al.
VIROLOGY (2011)
APOBEC3 Proteins Expressed in Mammary Epithelial Cells Are Packaged into Retroviruses and Can Restrict Transmission of Milk-Borne Virions
Chioma M. Okeoma et al.
CELL HOST & MICROBE (2010)
Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics
John S. Albin et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2010)
APOBEC3G Generates Nonsense Mutations in Human T-Cell Leukemia Virus Type 1 Proviral Genomes In Vivo
Jun Fan et al.
JOURNAL OF VIROLOGY (2010)
The Localization of APOBEC3H Variants in HIV-1 Virions Determines Their Antiviral Activity
Marcel Ooms et al.
JOURNAL OF VIROLOGY (2010)
APOBEC3F and APOBEC3G Inhibit HIV-1 DNA Integration by Different Mechanisms
Jean L. Mbisa et al.
JOURNAL OF VIROLOGY (2010)
Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses
Ana-Monica Pais-Correia et al.
NATURE MEDICINE (2010)
APOBEC3 proteins mediate the clearance of foreign DNA from human cells
Mark D. Stenglein et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction
Eric W. Refsland et al.
NUCLEIC ACIDS RESEARCH (2010)
Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission
Nancy Van Prooyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Quantitative Comparison of HTLV-1 and HIV-1 Cell-to-Cell Infection with New Replication Dependent Vectors
Dmitriy Mazurov et al.
PLOS PATHOGENS (2010)
Polymorphisms and Splice Variants Influence the Antiretroviral Activity of Human APOBEC3H
Ariana Harari et al.
JOURNAL OF VIROLOGY (2009)
Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets
Fransje A. Koning et al.
JOURNAL OF VIROLOGY (2009)
Are Viruses Inhibited by APOBEC3 Molecules from Their Host Species?
Susan R. Ross
PLOS PATHOGENS (2009)
Deaminase-Independent Inhibition of Parvoviruses by the APOBEC3A Cytidine Deaminase
Inigo Narvaiza et al.
PLOS PATHOGENS (2009)
The APOBEC3 cytidine deaminases: An innate defensive network opposing exogenous retroviruses and endogenous retroelements
Ya-Lin Chiu et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients' T cells by the viral tax oncoprotein
Klemens Pichler et al.
BLOOD (2008)
Antiretroelement activity of APOBEC3H was lost twice in recent human evolution
Molly OhAinle et al.
CELL HOST & MICROBE (2008)
Human cytidine deaminase APOBEC3H restricts HIV-1 replication
Ying Dang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960
Michael Worobey et al.
NATURE (2008)
MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes
Klemens Pichler et al.
RETROVIROLOGY (2008)
HIV-I Vif, APOBEC, and intrinsic immunity
Ritu Goila-Gaur et al.
RETROVIROLOGY (2008)
Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions
Jean-Pierre Vartanian et al.
SCIENCE (2008)
Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells
Gustavo H. Kijak et al.
VIROLOGY (2008)
Inhibition of Alpharetrovirus replication by a range of human APOBEC3 proteins
Heather L. Wiegand et al.
JOURNAL OF VIROLOGY (2007)
Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G
Yasumasa Iwatani et al.
NUCLEIC ACIDS RESEARCH (2007)
Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity
Ritu Goila-Gaur et al.
RETROVIROLOGY (2007)
The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains
Hal P. Bogerd et al.
VIROLOGY (2007)
Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression
Gang Peng et al.
BLOOD (2007)
Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration
Jean L. Mbisa et al.
JOURNAL OF VIROLOGY (2007)
Population stratification of a common APOBEC gene deletion polymorphism
Jeffrey M. Kidd et al.
PLOS GENETICS (2007)
Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid
David Derse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation - Comparisons with APOBEC3G
Rebecca K. Holmes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation
Masao Matsuoka et al.
NATURE REVIEWS CANCER (2007)
Human T cell leukemia virus type I is resistant to the antiviral effects of APOBEC3
Takeo Ohsugi et al.
JOURNAL OF VIROLOGICAL METHODS (2007)
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination
Kate N. Bishop et al.
JOURNAL OF VIROLOGY (2006)
APOBEC3 proteins inhibit human LINE-1 retrotransposition
Heide Muckenfuss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition
Hal P. Bogerd et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes
Katja Waeldele et al.
BLOOD (2006)
APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons
H Chen et al.
CURRENT BIOLOGY (2006)
APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells
HP Bogerd et al.
NUCLEIC ACIDS RESEARCH (2006)
Global epidemiology of HTLV-I infection and associated diseases
FA Proietti et al.
ONCOGENE (2005)
HTLV-1 tropism and envelope receptor
N Manel et al.
ONCOGENE (2005)
Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases
R Mahieux et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif
BP Doehle et al.
VIROLOGY (2005)
Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo
R Suspène et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
APOBEC3G targets human T-cell leukemia virus type 1
A Sasada et al.
RETROVIROLOGY (2005)
A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II
DF Roucoux et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
The clonal expansion of human T lymphotropic virus type 1-infected T cells: A comparison between seroconverters and long-term carriers
G Tanaka et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Complementary function of the two catalytic domains of APOBEC3G
F Navarro et al.
VIROLOGY (2005)
Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity
ENC Newman et al.
CURRENT BIOLOGY (2005)
Recovery of APOBEC3-edited human immunodeficiency virus G -> A hypermutants by differential DNA denaturation PCR
R Suspene et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway
A Mehle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cytidine deamination of retroviral DNA by diverse APOBEC proteins
KN Bishop et al.
CURRENT BIOLOGY (2004)
Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I
HC Li et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G
SG Conticello et al.
CURRENT BIOLOGY (2003)
Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex
XH Yu et al.
SCIENCE (2003)
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif
R Mariani et al.
CELL (2003)
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
B Mangeat et al.
NATURE (2003)
DNA determination mediates innate immunity to retroviral infection
RS Harris et al.
CELL (2003)
Hypermutation of HIV-1 DNA in the absence of the Vif protein
D Lecossier et al.
SCIENCE (2003)
Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton
T Igakura et al.
SCIENCE (2003)
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
AM Sheehy et al.
NATURE MEDICINE (2003)
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
M Marin et al.
NATURE MEDICINE (2003)
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
AM Sheehy et al.
NATURE (2002)
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
XP Wei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
CD8+ T cells are an in vivo reservoir for human T-cell lymphotropic virus type I
M Nagai et al.
BLOOD (2001)
Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4+ T cells
M Janini et al.
JOURNAL OF VIROLOGY (2001)
Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors
D Derse et al.
JOURNAL OF VIROLOGY (2001)
Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309
T Ruckes et al.
BLOOD (2001)
Dating the origin of the African human T-cell lymphotropic virus type-I (HTLV-I) subtypes
S Van Dooren et al.
MOLECULAR BIOLOGY AND EVOLUTION (2001)
In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy
LM Mansky
JOURNAL OF VIROLOGY (2000)
Share Paper
